|
HS Code |
936752 |
| Name | Cytidylic Acid |
| Chemical Formula | C9H14N3O8P |
| Molecular Weight | 323.20 g/mol |
| Cas Number | 63-37-6 |
| Appearance | White or off-white powder |
| Iupac Name | Cytidine 5'-monophosphate |
| Solubility In Water | Freely soluble |
| Melting Point | 236-240°C (decomposes) |
| Ph Of Solution | 2.5-3.5 (1% solution) |
| Storage Conditions | Store at 2-8°C, keep container tightly closed |
| Purity | Typically ≥98% |
| Synonyms | CMP, Cytidine monophosphate |
As an accredited Cytidylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Cytidylic Acid is packaged in a 25 g amber glass bottle with a sealed screw cap, labeled with safety and identification details. |
| Shipping | Cytidylic Acid is shipped in tightly sealed containers, protected from moisture and light, and stored at room temperature. Handling requires appropriate personal protective equipment. Transportation complies with regulations for non-hazardous chemicals, ensuring no exposure to heat or incompatible substances. Proper labeling and documentation accompany all shipments for safety and traceability. |
| Storage | Cytidylic Acid should be stored in a tightly closed container, protected from moisture and light. Keep it at a temperature between 2–8°C (refrigerated) and in a well-ventilated, dry area away from incompatible substances. Ensure appropriate labeling and prevent exposure to heat or strong oxidizers. Follow safety protocols and local regulations for chemical storage and handling. |
|
Purity 99%: Cytidylic Acid with 99% purity is used in pharmaceutical synthesis, where it ensures high-yield and low-impurity active ingredient production. Molecular weight 323.2 g/mol: Cytidylic Acid of molecular weight 323.2 g/mol is used in nucleotide synthesis processes, where it guarantees accurate sequence incorporation. Aqueous solubility 50 mg/mL: Cytidylic Acid with 50 mg/mL aqueous solubility is used in injectable formulation development, where it achieves rapid and complete dissolution. Stability at 25°C: Cytidylic Acid stable at 25°C is used in long-term experimental storage, where it maintains chemical integrity over extended periods. Particle size <50 microns: Cytidylic Acid with particle size below 50 microns is used in cell culture media preparation, where it promotes uniform distribution and enhanced cellular uptake. Pyrogen-free: Cytidylic Acid that is pyrogen-free is used in biomanufacturing applications, where it minimizes the risk of endotoxin contamination in finished biologics. Melting point 210°C: Cytidylic Acid with a melting point of 210°C is used in thermo-sensitive research studies, where it allows for controlled thermal processing without degradation. |
Competitive Cytidylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Cytidylic acid catches the eye of anyone who’s spent time in a genomics lab or has an interest in the chemistry that ties our bodies together. It’s the molecule behind the “C” in RNA sequences, and over the years, it’s played a far bigger role than many realize. This compound, known by scientists as 5’-cytidylic acid or CMP, is as real to a molecular biologist as a screwdriver is to a carpenter. People who move pipettes for a living can spot its formula—C9H14N3O8P—without blinking. Just from my own days sorting through stacks of sequencing samples, I know the impact a solid supply of cytidylic acid can have when you’re facing a backlog of experimental projects that can’t run without the right reagents.
For anyone trying to bridge the gap between lab research and practical results, the details matter. Cytidylic acid doesn’t just show up once; it cycles through from the prep of RNA standards and calibration curves, through the chase for cleaner, purer pharmaceuticals, to the slow grind of creating better diagnostic kits for viral infections or genetic disorders. People on both sides of benches—researchers, technicians, clinicians—recognize how a reliable batch of cytidylic acid saves them from troubleshooting headaches. That hits close to home. Every time I watched colleagues run into problems with purity, consistency, or even lost vials, the implications were immediate. Progress slowed to a crawl. It’s not some “behind-the-scenes” factor; the right biomolecule changes how fast a team can find answers and how confident they feel about the data they produce.
For the typical scientist or technician, having a product that comes as a white crystalline solid with a known melting point means one less thing to worry about. The distinct look and feel of high-grade cytidylic acid go beyond basic quality control. Scientists look for products where the color, solubility, and storage instructions make sense, because sloppy details in reagents end up making the next week’s work harder and less predictable. That’s personal. Over the years, I’ve come to expect that any product labelled GMP-grade should be able to back it up: purity of at least 98 percent, no random metallic contamination, and no unexplainable degradation before its listed shelf life. If a company can’t provide ATPase and nuclease test results, or if a batch smells off when you open the bottle, trust disappears fast. Trust, in a lab, is nearly everything.
Specs shape outcomes in every chemistry purchase. Labs that buy cytidylic acid by the gram expect certain standards, not marketing fluff. Water content, pH range in aqueous solution, and guaranteed absence of other nucleotides build the backbone of a dependable research day. If cytidylic acid claims to work for both pharmaceutical research and industrial fermentation, the evidence needs to appear in consistent yields and clean performance—especially under stress, like during 24-hour bioreactor runs or long-haul cold storage. Back when one group I knew tried using a generic knock-off, we saw unexpected UV spectrometry blips and, worse, mysterious results in HPLC traces. Switching to a GMP-certified source fixed it, but we lost two months. That lesson stuck around, making me far less tolerant of vague claims and unproven specs.
There’s also the matter of formats and packaging. Whether cytidylic acid comes in glass vials or lined polyethylene jars, the handling process affects benchwork rhythm. No one likes scraping powders or guessing at moisture uptake on humid days. A product that stays stable in variable climates, resists caking, and allows easy weighing takes pressure off the person prepping morning solutions. The little things add up: fewer headaches mean more focus left for solving the big questions, not resolving mysteries created by a flawed supply chain. I’ve stood over more than one bench trying to coax dusty, lumped-up chemicals into solution, cursing the vendor for careless packaging. Most lab folk have, if they’re honest.
The reach of cytidylic acid stretches past academic labs. Whether you’re manufacturing antiretroviral drugs, developing mRNA vaccines, or validating testing kits for rare metabolic syndromes, precision in composition and quality impacts far more than a single experiment. Each protocol draws on that same bedrock: accurate concentration, biological activity, and stability from fridge to reaction vessel. These days, companies designing high-throughput workflows for CRISPR screens or diagnostic qPCR need nucleotide monophosphates that mix cleanly with minimal background activity. Even basic research, like studying ribonuclease specificity or mapping methylation patterns, can get derailed by contaminants in the supply chain.
The effects trickle outward. Graduate students facing buffer failures or mystery precipitates waste real time, often feeling the heat from advisers or grant deadlines. Postdocs and industry scientists spot subtle background noise in chromatography runs—hours spent combing through false positives or repeating controls. That drains momentum and scares off investment. In the high-stakes world of pharmaceutical R&D, late-stage failure driven by subpar nucleotide standards can tank entire drug programs, with millions of dollars and years of work down the drain. Anyone who has worked in a busy diagnostics lab knows the stress of waiting for that one last shipment or chasing down purity reports for regulatory filings. There is no appetite for improvising with stand-ins when careers and patient outcomes are tangled up in the results.
People sometimes lump cytidylic acid together with adenylic acid, guanylic acid, or uridylic acid, as if they all play interchangeable roles. That’s a mistake. Sure, all four are monophosphates and share a backbone, but each brings unique properties to the table. Cytidylic acid carries the cytosine base, which offers a different hydrogen bonding landscape than adenine or guanine. That difference shows up in how enzymes process RNA substrates, as well as how synthetic oligonucleotides fold and function. From practical experience assembling reagents for RT-PCR, I learned to never substitute one mononucleotide for another unless the protocol spells it out—reaction rates and binding specificities jump all over the place.
Cytidylic acid also matters because of its connections to cellular energy metabolism. It stands at a key node in the pyrimidine biosynthesis pathway, which pharmaceutical scientists exploit for both anti-viral and anti-cancer drug design. Some research groups depend on this compound to chase down rare metabolic mutations or explore new frontiers in synthetic biology. In contrast to ATP and GTP, cytidylic acid rarely steals the limelight for energy transfer, but its precise role in transcription and cell signaling gives it a distinct profile in any workflow seeking authentic, natural nucleic acid chemistry.
That difference becomes more pronounced in custom synthesis or high-purity settings. Technical demands have only gotten tougher over the years, with sterile-filtered, pyrogen-free, or endotoxin-scrubbed grades now becoming baseline requirements in vaccine manufacturing or advanced gene editing studies. Not every vendor can meet these demands, and not every lot performs the same. The days of “good enough” have disappeared. That’s been clear from the times I’ve had to toss entire projects due to a flaky nucleotide supplier: trust is hard-won and easily lost.
Every purchase represents a choice shaped by the realities of the market and the limits of time. Pressure always builds around budgets, deadlines, and the tension of staying compliant with regulatory expectations. It’s easy for managers to stare at spreadsheets and only see the price per gram. I’ve watched procurement officers lean on the cheapest option, only to pay double later when purity or documentation didn’t pan out. Labs can’t afford to play roulette with the biologicals that power their next grant or diagnostic launch. Even in less regulated academic circles, the price of cutting corners gets paid in the late hours, repeating experiments, and the lost goodwill once colleagues realize what went wrong.
Documented traceability, open certificates of analysis, and responsive tech support figure into every serious lab’s purchasing plan. I’ve spent enough time haggling with unresponsive vendors to appreciate the companies who update their batches, flag potential issues, or keep up with the latest pharmacopeial standards. There’s nothing theoretical about the scramble for compliance or the sting of realizing expiration dates were fudged. The labs I respect most set up internal tracking spreadsheets and regularly audit their chemical inventories, some even running molar concentration checks or mini-purity runs before every big batch. It may seem obsessive, but too many experimenters have been burned by an unexpected contaminant or shift in supplier standards.
Labs and vendors both carry the load in keeping quality high and risk low. For buyers, thorough due diligence up front saves pain in the long run. This includes checking for ISO certification, reading third-party reviews, and digging deeper than the surface specs—a practice that’s saved my own projects on more than one occasion. Choosing suppliers who share robust support documents, including full analytical profiles, limits the guesswork when troubleshooting begins. Engaged staff on both sides shape the health of every scientific project, because it’s real people that notice when a label’s printed with the wrong lot number or when a powder isn’t flowing as expected.
The wider scientific community can do its part by sharing feedback and supporting open forums where people compare experiences and flag repeat offenders. Some universities and industry groups now require new chemicals to clear extra rounds of in-house verification, even building shared databases of “trusted” products based on collective experience. Transparency wins every time: the more people who see and understand the sourcing process, the fewer surprises show up when it matters most.
The industry has also taken steps toward smarter packaging, such as pre-measured aliquots, tamper-proof lids, and packaging that locks out excess moisture. I’ve personally seen the difference a vacuum-sealed container made on a summer day with humidity pushing 90 percent. Some groups are even trialing RFID tags that monitor temperature history—a welcome upgrade from scribbled freezer logs and assorted misremembered arrival dates. As supply chains globalize, these touches matter, especially as shipments bounce between climate zones or wait in customs longer than anyone planned. With so much riding on every experiment, every solution that adds real-world reliability to the product matters.
Biotech continues to leap forward, and products like cytidylic acid no longer sit unnoticed on the sidelines. The pace of change, from gene therapies to molecular diagnostics, shines a light on every link in the supply chain—sometimes brighter than anyone expected. When I think about the breakthroughs that punctuate modern science—rapid COVID vaccine development, improved rare disease screening, smarter agricultural genomics—I see the hands-on consequences of reagent quality on a global scale. Individual vials of cytidylic acid, engineered for precision and purity, play quiet but pivotal roles behind many of those wins.
Trusted raw materials underpin everything, especially as regulatory expectations tighten and more therapies slip from idea phase to clinical reality. Public trust depends on it too—people want to know that scientists aren’t gambling with short cuts on the molecular level. It comes down to discipline in everyday actions, treating each bottle, each gram, as mission-critical. Walking through cold rooms and supply closets, I see the future built on attention to these details every day. I’ve felt the collective sigh of relief from teams who know their standards are tight and their batches reliable.
Cytidylic acid rarely gets star treatment, but anyone working at the lab bench knows the compound’s value. Building a robust, mistake-resistant pipeline for research or manufacturing means treating even the smallest vial as a strategic resource. High standards, careful supplier vetting, and dynamic feedback loops between users and producers all count toward ensuring each gram fulfills its purpose—whether fueling cutting-edge therapies or building tomorrow’s diagnostic kits. If my own career in the lab has taught me anything, it’s that what feels like “just another nucleotide” today could become the lynchpin for something bigger tomorrow.